RFK Jr. invested in gene-editing technology; financial disclosures show that he plans to divest stock holdings in CRISPR Therapeutics (CRSP), according to STAT News
- "WASHINGTON — President Trump’s nominee to lead the health department, Robert F. Kennedy Jr., invested in gene-editing technology and is owed substantial advances for several books, according to financial disclosures released ahead of his confirmation hearings.
- The disclosures give the clearest view to date of RFK Jr.’s investments, employment, and potential conflicts of interest. They show that he plans to divest stock holdings, including stakes in biotech firms CRISPR Therapeutics AG and Dragonfly Therapeutics. He’s also stepping down from roles at his law firm and at the anti-vaccine nonprofit Children’s Health Defense."
Reaction details (19:48)
CRSP shares rallied from 43.83 to 45.75/shr over 20 minutes before paring to 44.50.
Analysis details (19:48)
RFK Jr is US President Trump's pick for health secretary, therefore he will have to divest stocks he holds to prevent conflict of interests.
22 Jan 2025 - 19:18- - Source: STAT News
Subscribe Now to Newsquawk
Click here for a 1 week free trial
Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include:
- Real-time audio coverage from 0630 to 2200 London time plus Asia-Pac 2200 to 1000 London time
- Teams of analysts covering equities, fixed income, FX, energy, and metals markets
- Real-time scrolling news service with instant analysis
- Daily and weekly pre-market research and calendars
- Video updates covering near-term key risk events & primary trading themes
- One-to-one chat with our expert analysts